Press "esc" to clear
Go to Advanced Search

Showing results

110 of 1191

Article ID: 702360

HIV/AIDS Training Center at UIC Receives $4.4 Million in New Federal Funding

University of Illinois at Chicago

The Midwest AIDS Training and Education Center (MATEC) at the University of Illinois at Chicago has received $4.4 million in funding from the federal government to advance its work improving HIV/AIDS care, prevention and education in Illinois, Indiana, Iowa, Kansas, Michigan, Minnesota, Missouri, Nebraska, Ohio and Wisconsin.

17-Oct-2018 12:05 PM EDT

Article ID: 702246

HIV-Positive Infants Are at High Risk for Acquiring Congenital Cytomegalovirus Infection

University of California, Los Angeles (UCLA), Health Sciences

FINDINGS Infants born to HIV-positive mothers had high rates of congenital cytomegalovirus, or CMV. Infants who also were infected before birth by the virus that causes AIDS were especially prone to CMV infection. The researchers found that 23 percent of the infants who became infected with HIV during the mother’s pregnancy also were infected with CMV; 18 percent who were infected with HIV either during pregnancy or birth acquired congenital CMV; and 4.

15-Oct-2018 4:05 PM EDT

Article ID: 702132

Researchers Document History Of Fear In Public Health Campaigns

Texas A&M University

Fear never works. Or does it? Fear can be a powerful tool in public health efforts, although graphic, emotionally evocative campaigns have been the source of controversy over the past half-century.

12-Oct-2018 3:05 PM EDT

Social and Behavioral Sciences


Article ID: 701955

UNC to Create the Next Generation, Ultra-Long-Acting Antiretroviral Formulations for HIV Treatment and Prevention

University of North Carolina School of Medicine

Researchers at the UNC School of Medicine have been awarded a 5-year, $3.8 million grant from the National Institute of Allergy and Infectious Diseases to develop next generation, ultra-long-acting antiretroviral formulations for HIV treatment and prevention that have the potential to dramatically improve adherence.

10-Oct-2018 9:00 AM EDT

Article ID: 701800

Long-acting Injectable implant shows promise for HIV treatment and prevention

University of North Carolina School of Medicine

Currently, a once-daily pill to prevent HIV infection is available. However, adherence to a once-daily regimen can be difficult for some people. Researchers from the UNC School of Medicine and the Centers for Disease Control and Prevention published a study today in Nature Communications that reports a potentially promising remedy for this problem.

8-Oct-2018 11:05 AM EDT

Article ID: 701771

NUS researchers uncover new role of TIP60 protein in controlling tumour formation

National University of Singapore

Scientists from the Cancer Science Institute of Singaporeat the National University of Singapore have discovered a new molecular pathway that controls colorectal cancer development, and their exciting findings open new therapeutic opportunities.

7-Oct-2018 10:05 PM EDT

Article ID: 701658

Reducing HIV, other STIs among young black women in South Africa

University of Illinois at Chicago

The University of Illinois at Chicago is one of eight universities awarded funding by the National Institutes of Health to prevent and treat sexually transmitted infections, including HIV, among adolescents and young adults in Africa and Brazil. Collectively, the international projects are known as Prevention and Treatment through a Comprehensive Care Continuum for HIV-affected Adolescents in Resource Constrained Settings (PATC3H).

4-Oct-2018 11:05 AM EDT

Article ID: 701571

University Venture Fund Ii Is First Money in Navigen Pharmaceuticals Seed Round

Sorenson Impact Center, David Eccles School of Business, University of Utah

he Sorenson Impact Center’s University Venture Fund - Impact Investing (UVF II) closed its first investment in a seed round into Salt Lake City-based Navigen, Inc.

3-Oct-2018 1:05 PM EDT

Showing results

110 of 1191

Chat now!